Breast Lesion Localization Methods Market Worth 877.9 Million USD by 2020
PUNE, India, April 15, 2016 /PRNewswire/ --
According to a new market research report "Breast Lesion Localization Methods Market Comparative Analysis and End User Preference Study - (Market Assessment (Field Force, Comparative Analysis, Business Model, End User Preference Survey (Selection Criteria, Qualitative Analysis of Replacement Trend), Competitive Product Portfolio and Strategic Consolidation)", published by MarketsandMarkets, The market is estimated to reach USD 877.9 Million by 2020 from USD 445.9 Million in 2015, at a CAGR of 14.5% from 2015 to 2020.
(Logo: http://photos.prnewswire.com/prnh/20160303/792302 )
Browse 55 Slides and in-depth TOC on "Breast Lesion Localization Methods Market"
Early buyers will receive 10% customization on this report.
The report analyzes and studies breast lesion localization methods in terms of replacement trends, competitor portfolio, and selection criteria for adopting breast lesion localization methods from an end-user perspective. It also provides a detailed overview of the major drivers, restraints, opportunities, challenges, current market trends, and strategic consolidations impacting the market, along with estimates and forecasts of revenue.
The overall market for breast lesion localization methods is expected to witness rapid growth owing to the increasing number of breast cancer surgeries and implementation of favorable reimbursement guidelines. Furthermore, the rising demand for better quality care and growing awareness amongst patients about breast cancer screening are the other major factors driving the breast lesion localization methods market. On the other hand, market growth will be restrained by the uncertainty in regulatory approval procedures as a result of the risks associated with breast lesion localization devices. However, force field analysis of the market depicts that the driving forces outweigh the restraining forces.
Based on the type of localization devices, the market is segmented into wire localization, radioisotope localization (radioactive seed localization, radio occult lesion localization), magnetic tracers, and others. Among these segments, wire localization is the major focus of players as it is an established technique in the market. Also, the comparative analysis of four major types of localization methods shows that wire localization is still the gold standard for breast localization, resulting in continued adoption of this technique among end users. However, according to the replacement trends studied in all geographies, most end users are expected to switch from wire localization to radio-guided localization methods (especially radioactive seed localization) in the near future.
Talk to our Experts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=35768623
This report contains detailed analysis of end user preferences for the adoption of different breast lesion localization methods. The research findings cited in the report encapsulate the important selection criteria for breast lesion localization methods from an end-user perspective. It analysis the importance given to a particular criteria by end users during the selection of a breast lesion localization method; some of the important selection criteria include detection and success rate, re-excision rate, cost, mean localization time, effectiveness, safety, ease of use, and mean operating time.
Browse Related Reports:
Breast Biopsy Market by Product (Table, Needle, Localization wire, Guidance System), Type (Open Biopsy- Excisional, Incisional, Needle- Core Needle Aspiration, Vacuum Assisted) & by Guidance system (Ultrasound, Stereotactic, MRI) - Forecast to 2020
http://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market-189011805.html
Cancer Diagnostics Market by Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma) - Forecast to 2020
http://www.marketsandmarkets.com/Market-Reports/cancer-diagnostics-market-186559121.html
About MarketsandMarkets
MarketsandMarkets is the world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: [email protected]
SOURCE MarketsandMarkets
Share this article